DNMT1 and acute myeloid leukemia: Another AuNP with adsorbed high-density lipoprotein (HDL) downregulating DNMT1 by delivering BMS309403 has been designed, which induces AML cell differentiation, and interrupts AML progression without obvious side effects [115].